TELES Informationstechnologien AG (TLIK) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of TELES Informationstechnologien AG stock €0.12, price €0.28, that is 56.8% below the price, quality 31 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
TELES Informationstechnologien AG
TLIK · XETRAFar too expensive (fair value 57% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.
How to read this chart
60‑month range €0.1000 – €8.95 · fair‑value band €0.0907 – €0.1511 · the €0.2800 price screens above the €0.1209 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 10, 2026.
Every Wednesday you see whether TELES Informationstechnologien is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.
Stock analysis
TELES Informationstechnologien AG (TLIK) currently trades at €0.2800, while our estimate is €0.1209, 57% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: €0.0907 (bear) to €0.1511 (bull), the price of €0.2800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2021: revenue and profit before it include the divested business. Growth is measured afresh from 2021.
TELES Informationstechnologien AG reported revenue of €658K in FY2024 versus €2.8M in FY2020, a compound −30.5%/yr. Reported net income was −€835K in FY2024.
Key figures
Market cap €3.8M Micro · P/S ratio 15.9 · EPS (TTM) €−0.1300 · Net margin −127% · Return on equity −96.8% · Return on assets (EBIT) −24.2% (5-year average) · Operating margin −284% · Revenue (TTM) €239K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).
What moves the price
The share trades about 48% below its 52-week high and 180% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −57%, TLIK screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
TLIK screens overvalued: fair value 57% below the price. Compare with McKesson Corporation →
Compare TELES Informationstechnologien AG with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 81 stocks
Valuation Multiplesvs Medical Distribution median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Information Technology sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: German Stocks
- Valuation of the Germany market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Sinopharm Group 1099 | HK$16.87 | HK$50.61 | +200% | vs TLIK |
| Jointown Pharmaceutical Group 600998 | ¥5.27 | ¥11.56 | +119% | vs TLIK |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.54 | ¥35.78 | +116% | vs TLIK |
| China National Medicines Corporation 600511 | ¥28.87 | ¥58.47 | +103% | vs TLIK |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥19.68 | ¥26.64 | +35% | vs TLIK |
| Cencora, Inc COR | $350.56 | $341.58 | −3% | vs TLIK |
| Henry Schein, Inc HSIC | $82.94 | $78.69 | −5% | vs TLIK |
| McKesson Corporation MCK | $1,092 | $822.74 | −25% | vs TLIK |
| Galenica AG GALE | CHF 90.30 | CHF 61.79 | −32% | vs TLIK |
| Cardinal Health, Inc CAH | $279.25 | $163.14 | −42% | vs TLIK |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is TELES Informationstechnologien AG (TLIK) overvalued or undervalued?
What is the fair value of TLIK?
What is the quality score of TLIK?
What is the price target for TELES Informationstechnologien AG (TLIK)?
What is the TELES Informationstechnologien AG stock forecast for 2026?
What is the revenue of TELES Informationstechnologien AG (TLIK)?
What is the intrinsic value of TELES Informationstechnologien AG (TLIK)?
Is TELES Informationstechnologien AG stock overvalued or undervalued in 2026?
Is fair value the same as the market price of TLIK?
How much is TELES Informationstechnologien AG worth?
What do the bullish and bearish scenarios say about TLIK?
How solid is the balance sheet of TELES Informationstechnologien AG (TLIK)?
How far is TLIK from its 52-week high?
Which stocks are comparable to TELES Informationstechnologien AG?
Is TELES Informationstechnologien AG stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of TELES Informationstechnologien AG (TLIK)?
What should I pay attention to with TELES Informationstechnologien AG right now?
Key figures of TELES Informationstechnologien AG
How large is the market capitalisation of TELES Informationstechnologien AG (TLIK)?
What is the P/S ratio of TELES Informationstechnologien AG (TLIK)?
What are the earnings per share of TELES Informationstechnologien AG (TLIK)?
What is the net margin of TELES Informationstechnologien AG (TLIK)?
What is the return on equity of TELES Informationstechnologien AG (TLIK)?
What is the EBIT return on assets of TELES Informationstechnologien AG (TLIK)?
What is the operating margin of TELES Informationstechnologien AG (TLIK)?
How fast is revenue growing at TELES Informationstechnologien AG (TLIK)?
How fast are earnings growing at TELES Informationstechnologien AG (TLIK)?
How much free cash flow does TELES Informationstechnologien AG (TLIK) generate?
How much net debt does TELES Informationstechnologien AG (TLIK) carry?
Watch TELES Informationstechnologien AG in the live analysis
One click puts TELES Informationstechnologien AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.